President & CEO, Cell Signaling Technology, Inc
Dr. Comb is interested in the communication that occurs within and between cells. In cancer, this communication is defective. By understanding the nature of the communication and the ways that it is changed in cancer, he hopes to help develop better treatments and diagnostic tools. In this interview he discusses his work on cell signaling and the development of new model systems to study cancer. He also talks about the need for young people to get involved in biomedical research.
Interview Questions
About Dr. Michael Comb
(Time:
15sec
)
How Comb Became Involved in Cancer Research And Signaling Pathways
(Time:
1min
3sec
)
Signaling Pathways and Cancer
(Time:
2min
29sec
)
Making Cell Signaling Technology More Accesible
(Time:
1min
3sec
)
Identifying the Problem With Cells at a Molecular Level
(Time:
1min
35sec
)
Unigraphs and the Need For Better Model Systems
(Time:
1min
23sec
)
Developing Better Tools to Identify More Signaling Pathways
(Time:
1min
6sec
)
Current Limitations Associated with Cell Signaling Pathway Research
(Time:
2min
53sec
)
The Use of Antibodies to Discover Cell Damage
(Time:
1min
21sec
)
Students Working at Cell Signaling Technology
(Time:
52sec
)
Encouraging the Youth to Engage in Science
(Time:
1min
2sec
)